A group 13 homeodomain is neither necessary nor sufficient for posterior prevalence in the mouse limb  by Williams, Melissa E. et al.
97 (2006) 493–507
www.elsevier.com/locate/ydbioDevelopmental Biology 2A group 13 homeodomain is neither necessary nor sufficient for
posterior prevalence in the mouse limb
Melissa E. Williams a, Jessica A. Lehoczky a, Jeffrey W. Innis a,b,⁎
a Department of Human Genetics, University of Michigan, Ann Arbor, MI 48109, USA
b Department of Pediatrics, Division of Genetics, University of Michigan, Ann Arbor, MI 48109, USA
Received for publication 22 December 2005; revised 18 May 2006; accepted 22 May 2006
Available online 26 May 2006Abstract
Posterior prevalence is the general property attributed to HOX proteins describing the dominant effect of more posterior HOX proteins over the
function of anterior orthologs in common areas of expression. To explore the HOX group 13 protein domains required for this property, we used
the mouse Prx-1 promoter to drive transgenic expression of Hox constructs throughout the entire limb bud during development. This system
allowed us to conclusively demonstrate a hierarchy of Hox function in developing limbs. Furthermore, by substituting the HOXD11 or HOXA9
homeodomain for that of HOXD13, we show that a HOXD13 homeodomain is not necessary for posterior prevalence. Proximal expression of
these chimeric proteins unexpectedly caused defects consistent with wild-type HOXD13 mediated posterior prevalence. Moreover, group 13 non-
homeodomain residues appear to confer the property as proximal expression of HOXA9 containing the HOXD13 homeodomain did not result in
limb reductions characteristic of HOXD13. These data are most compatible with models of posterior prevalence based on protein–protein
interactions and support examination of the N-terminal non-homeodomain regions of Hox group 13 proteins as necessary agents for posterior
prevalence.
© 2006 Elsevier Inc. All rights reserved.Keywords: Posterior prevalence; HOXD13; Hox; Homeodomain; LimbIntroduction
Hox genes are crucial developmental regulators in animals.
The 5′ members of the A and D clusters, corresponding to
paralog groups 9–13, evolved from a single ancestral gene
related to Drosophila Abdominal B (AbdB) and are expressed
during limb outgrowth (Dolle et al., 1989; Haack and Gruss,
1993; Izpisua-Belmonte et al., 1991; Nelson et al., 1996;
Yokouchi et al., 1991).
Initiation and maintenance of the precise expression domains
of Hox genes are critical for normal patterning. Generally, it has
been shown that each AbdB-like paralog group expressed in the
limb, 9–13, contributes primarily to the growth of one selected
segment (Davis et al., 1995; Fromental-Ramain et al., 1996;⁎ Corresponding author. Department of Human Genetics, University of
Michigan, Med. Sci. II 4811, Ann Arbor, MI 48109-0618, USA. Fax: +1 734
763 3784.
E-mail address: innis@umich.edu (J.W. Innis).
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doi:10.1016/j.ydbio.2006.05.027Rijli and Chambon, 1997; Small and Potter, 1993; Wellik and
Capecchi, 2003). Group 13 genes are most important for the
development of the autopod, group 11 for the zeugopod and
groups 9 and 10 for the stylopod.
Alteration, misexpression or gain-of-function in the expres-
sion of distally restricted Hox genes in the limb results in
shortening of skeletal elements usually in regions proximal to
their normal expression boundary (Caronia et al., 2003; Goff
and Tabin, 1997; Knezevic et al., 1997; Morgan et al., 1992;
Yokouchi et al., 1995). This phenomenon acting along the distal
to proximal axis of the limb is analogous to the dominance of
posteriorly expressed genes over anterior genes in the axial
skeleton (Balling et al., 1989; Kessel and Gruss, 1990; Lufkin et
al., 1992; McGinnis and Krumlauf, 1992; van den Akker et al.,
2001; Wellik and Capecchi, 2003). This property, referred to as
posterior prevalence (Duboule, 1991), has been studied in
chicks and mice and, with minor variations, this Hox functional
hierarchy is conserved from flies to mammals (Bachiller et al.,
1994; Duboule and Morata, 1994; Gonzalez-Reyes and Morata,
1990).
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effects of posterior prevalence and, when examined together,
suggest the likelihood of a functional hierarchy in the limb buds.
Misexpression of either Hoxd13 and Hoxa13 in chick limbs
results in shortening of bones in segments proximal to the
autopod consistent with posterior prevalence (Goff and Tabin,
1997; Yokouchi et al., 1995).Misexpression of twoN-terminally
truncated forms of HOXD13, lacking the first 80 or 98 amino
acids, leads to milder shortening of the skeletal elements of the
zeugopod, suggesting that the N-terminal region plays a role in
the activity of the protein but not the specificity. The
spontaneous mutant Ulnaless is an example of posterior
prevalence in the mouse (Herault et al., 1997; Peichel et al.,
1997; Spitz et al., 2003). The limbs of this mutant partially
resemble Hoxa11/Hoxd11 double homozygous null mice in that
the zeugopods are extremely reduced. This phenotype results
from abnormal proximal (zeugopodal) expression of Hoxd12
and Hoxd13, as well as downregulation of Hoxd11 expression
normally present within the zeugopod. Another study used the
Hoxb6 promoter to misexpress Hoxd12 in posterior lateral plate
mesoderm, the distal, posterior forelimb bud and the entire
hindlimb bud in transgenic mice (Knezevic et al., 1997).
Transgenicmice showed preaxial (anterior) posteriorization and/
or digit duplication, and reductions were isolated to preaxial
skeletal elements in the hindlimb (Knezevic et al., 1997).
Similarly, Morgan et al. (1992) and Goff and Tabin (1997) used
retroviral expression in chick limbs and showed that Hoxd11
induced preaxial polydactyly in wings and, like Hoxd12,
posteriorization of anterior digit I. However, Goff and Tabin
also found shortening of the leg zeugopods and concluded that
Hoxd11 could exert effects early during mesenchymal conden-
sation as well as later during bone growth.
The phenomenon of posterior prevalence is interrelated with
how different Hox proteins gain specificity in vivo (Duboule
and Morata, 1994; Gehring et al., 1994) and ultimately is
attributable to the primary amino acid sequence. In Drosophila,
the C-terminal region, including but not exclusive to the
homeodomain, which is involved in DNA binding and some co-
factor interactions, plays a critical role in specificity of function
(Chan and Mann, 1993; Gibson et al., 1990; Kuziora and
McGinnis, 1989; Lin and McGinnis, 1992; Mann and Hogness,
1990; Zeng et al., 1993). Studies in animal models also point to
the Hox homeodomain, as an important determinant of Hox
functional specificity (Chang et al., 1996; Furukubo-Tokunaga
et al., 1993; Kuziora and McGinnis, 1989; Lin and McGinnis,
1992; Mann and Affolter, 1998; Zappavigna et al., 1994; Zeng
et al., 1993; Zhao and Potter, 2001, 2002). For example, sub-
stitution of the HOXA11 homeodomain with that of HOXA13
in mice revealed that the homeodomain of HOXA13, though
duplicated from and highly similar to other AbdB-like HOX
homeodomains, is functionally different from that of HOXA11.
While the HOXA13 homeodomain showed equivalent function
to HOXA11 in the axial skeleton and the male reproductive
tract, it acted dominantly or with different function in the female
reproductive tract and in the developing limbs where it led to
shortening of the zeugopod (Zhao and Potter, 2002). However,
it is not known whether all functional differences, includingposterior prevalence, can be attributed solely to the amino acid
sequence of the homeodomain (Chauvet et al., 2000; Galant and
Carroll, 2002; Ronshaugen et al., 2002; Sreenath et al., 1996).
For example, gain-of-function studies in transgenic mice that
replaced the HOXA4 homeodomain with that of HOXC8
showed that the functional specificity of HOXA4 in the axial
skeleton is determined by non-homeodomain residues (Sreenath
et al., 1996). Moreover, non-homeodomain regions of HOX
protein paralogs diverge significantly, contain cofactor interac-
tion motifs and harbor activation and repression domains that
offer numerous opportunities for functional differences and
specificity to be achieved (Krumlauf, 1994; Mann and Morata,
2000; Merabet et al., 2003; Vigano et al., 1998; Williams et al.,
2005; Yaron et al., 2001).
In this work, we systematically test the contribution of amino
acid sequence to HOX group 13 posterior prevalence in the
mouse limb using one experimental system. The mouse Prx-1
promoter was used to drive mesenchymal transgenic expression
of Hox constructs (Martin and Olson, 2000) at early stages
during fore- and hindlimb development. We document
expression of the transgenic RNA and protein and describe
the phenotypes of transgenic founders and offspring. We show
that, as expected, a HOX functional hierarchy exists in the
developing limb. However, the non-homeodomain region of the
group 13 HOXD protein was capable of exerting posterior
prevalence with either a homeodomain from HOXD11 or
HOXA9. Moreover, despite our expectation that the HOXD13
homeodomain would be the primary functional determinant of
posterior prevalence, a HOXA9 protein with a HOXD13
homeodomain failed to exert posterior prevalence. These
studies support efforts to identify the non-homeodomain protein
motifs responsible for posterior prevalence.
Materials and methods
Transgene creation and injection
Hoxd13 (1–2814 bp, Genbank NM_008275), Hoxa13 (1–3101 bp,
NM_008264), Hoxd11 (−58–2231 bp, NM_008273) and Hoxa9 (1–3001 bp,
NM_010456) genomic DNA sequences were ligated within the BglII site of a
4.5 kb fragment containing the Prx-1 promoter (Martin and Olson, 2000; Post
et al., 2000). All Hox transgenes except Hoxd11 have a consensus Kozak
sequence (cccgccgccacc) engineered adjacent to the genuine start codon. The
Hoxd11 transgene includes 58 base pairs of endogenous 5′UTR sequence
upstream of the start codon. All genes use their respective introns, 3′ UTRs and
polyadenylation signals. Hoxd13IQN>AAA was created using PCR SOEing with
primers containing the sequence alterations (Horton et al., 1989). All constructs
were DNA sequence verified.
Prx1-Hox transgenes were digested with SalI to remove vector sequences,
gel purified and injected into fertilized B6/D2 F2 or B6/SJL F2 mouse eggs with
the help of the University of Michigan Transgenic Core Facility (www.med.
umich.edu/tamc/). Transgenic founders were identified by PCR using primers
specific to Prx-1 and the appropriate Hox gene.
Chimeric and mutant transgene construction
For the chimeric Hox constructs Prx1-Hoxd13d11HD and Prx1-Hoxd13a9HD,
the Hoxd11 or Hoxa9 homeobox replaces the Hoxd13 homeobox; all other
sequences are the same as Prx1-Hoxd13. Prx1-Hoxa9d13HD contains the Hoxd13
homeobox replacing the Hoxa9 homeobox; all other sequences are the same as
that for Prx1-Hoxa9. Chimeric and mutant constructs were generated using PCR
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PCR-induced mutations. Prx-1 is expressed as early as E9.5 in the lateral plate
mesoderm in the prospective limb fields before the limb bud is visualized
(Leussink et al., 1995). Expression continues throughout the undifferentiated
mesenchyme of developing limbs and is subsequently downregulated as cells
begin chondrogenic differentiation. Expression is maintained in the limb
through E17.5 within the perichondrium, dermis and developing tendons
(Leussink et al., 1995; Martin and Olson, 2000). Immunocytochemistry
confirmed expression of Prx1-Hox transgene constructs and proper nuclear
localization of the protein. Prx-1 driven HOXD13, HOXA13 and HOXA9
proteins were localized to the nucleus in transfected Cos-7 cells (data not
shown). HOXD11 expression could not be evaluated as there is no antibody
currently available.
Skeletal preparation and analysis
Transgenic founders were evaluated for limb skeletal malformations by
staining with Alcian blue and Alizarin red at selected stages (Kimmel and
Trammell, 1981). Transgenic progeny were generated for skeletal analysis by
crossing founders, when possible, with C57BL/6J mice. Images of skeletons
were captured using a DEI750 Optronics digital camera and Adobe Photoshop
software. Bone lengths were analyzed using the public domain NIH ImageJ
program (developed at the U.S. National Institutes of Health and available on the
Internet at http://rsb.info.nih.gov/nih-image/).
Whole-mount in situ hybridization
In situ hybridization using transgenic embryos of various stages was
completed and confirmed that the Prx-1 promoter drives transgene RNA
expression throughout the limb from E10.5 to E12.5 as previously reported
(Martin and Olson, 2000) (data not shown). All expression analysis was
performed using embryo offspring collected from matings of C57BL/6J mice
with transgenic founders at E10.5, E11.5, E12.5 or E13.5. Embryos were staged
by assigning noon of the day of vaginal plug as E0.5. 1114 base pairs of 3′UTR
from Hoxa9 were amplified from C57BL/6J RNA and ligated into the pCR4-
TOPO vector (Invitrogen). Hoxd13 and Hoxd11, and Shh (Echelard et al., 1993)
were kindly provided by D. Duboule and A. McMahon, respectively. Single-
stranded RNA probes were synthesized from these DNA templates. Whole-
mount in situ hybridization with a single digoxygenin-labeled RNA probe was
performed as previously described (Bober et al., 1994), except that BM purple
(Roche) was used as the substrate for alkaline phosphatase.
Whole-mount immunohistochemistry
Immunohistochemistry was performed as described (Yokouchi et al., 1995)
on wild-type and transgenic embryos collected at E11.5 or E12.5. The anti-
HOXA13 (Post et al., 2000), anti-HOXD13 (Williams et al., 2005) and rabbit
pre-immune serum were used at a dilution of 1:10,000. The secondary antibody
donkey anti-rabbit HRP-conjugate (Amersham) was used at a dilution of 1:500.
Preparation of limb bud lysates and western analysis
Embryos were collected at E12.5 from matings between transgenic founder
42 (Prx1-Hoxa9d13HD) and wild-type C57BL/6J females in cold PBS, pH 7.4.
Extra-embryonic membranes were removed and saved for DNA isolation and
genotyping. Distal and proximal segments of each limb were dissected, and all
distal and proximal segments from each embryo were pooled separately, snap
frozen in liquid nitrogen and stored at −80°C prior to genotyping. Equal
numbers of transgenic and wild-type limbs were pooled. Lysates were prepared
by homogenizing limb tissue in lysis buffer [10 mM HEPES (pH 7.5), 1 mM
EDTA, 250 mMNaCl, 0.5% NP-40, protease inhibitors (Roche)] and incubating
on ice for 25 min. After adding 5 M NaCl to a final concentration of 420 mM,
lysates were homogenized and incubated for 5 min on ice. Two microliters β-
mercaptoethanol was added to each lysate, and lysates were heated to 100°C for
5 min. Lysates were centrifuged at 5000 rpm for 5 min and supernatants
removed to fresh tubes and stored at −20°C (Chen et al., 2004). HOXA9
positive control lysate was created similarly using tissue culture cells transfected
with a pCMV5 driven Hoxa9 expression construct.Equal protein for each sample was separated by electrophoresis using 12%
SDS-polyacrylamide gels and subsequently electrotransferred to nitrocellulose.
Membranes were blocked by incubation with 5% Carnation milk for 1 h at room
temperature. Primary antibodies were used at 1:1000 for goat anti-HOXA9
(Santa Cruz Biotechnology, Inc) and 1:10,000 for rabbit anti-HOXD13
(Williams et al., 2005). The secondary antibodies, anti-goat HRP (Santa Cruz
Biotechnology, Inc) and anti-rabbit HRP-conjugated (Amersham), were used at
1:2000 and 1:10,000 respectively. Proteins were visualized using Supersignal
chemiluminescent substrate (Pierce).Results
HOXA13 and HOXD13 misexpression results in severe skeletal
reduction in proximal regions of mouse limbs
Hoxa13 and Hoxd13 are the most 5′ Hox genes within the A
and D clusters. These genes are the most distally restricted of the
Hox genes expressed in the developing limb bud and promote
growth of the autopod elements (Fromental-Ramain et al.,
1996). Based on prior experiments, we hypothesized that these
genes would pattern dominantly over other normally expressed
anterior AbdB-like Hox genes in the zeugopod and stylopod
upon whole limb transgenic expression (Goff and Tabin, 1997;
van der Hoeven et al., 1996; Yokouchi et al., 1995).
Founder analysis
Five Prx1-Hoxd13 and five Prx1-Hoxa13 transgenic foun-
ders were collected at E16.5 and prepared for skeletal staining.
Representative results of the phenotypic effects of transgenic
expression ofHoxd13 orHoxa13 throughout themesenchyme of
developing mouse limbs are shown in Fig. 1A, B and described
in Supplementary Tables 1 and 2. Every founder analyzed at
E16.5 had severe reduction of zeugopodal bones in both the fore-
and hindlimbs. Average zeugopod reductions in E16.5 Prx1-
Hoxd13 founders were: radius 92%, ulna 85%, tibia 89% and
fibula 89%. In E16.5 Prx1-Hoxa13 founders, the average
skeletal reductions were: radius 72%, ulna 80%, tibia 76% and
fibula 77%. Five of the ten Prx1-Hoxd13 and Prx1-Hoxa13
founders also had severe reduction/malformation of the
stylopods and scapulas; the other five founders had minimal
defects in these regions. Transgene expression also resulted in
variable preaxial polydactyly, of both fore- and hindlimbs, or
oligodactyly of the forelimbs in founders 712.1, 702.4 and
702.1. In non-limb regions, negative effects on the growth of the
skull and mandibular bones were also observed presumably due
to additional sites of Prx-1 promoter expression (Martin and
Olson, 2000), and such defects were associated with lethality
soon after birth.
Transgenic progeny
Two additional male Prx1-Hoxd13 founders, 706.6 and
713.7, were viable at birth, survived to reproductive age and
were mated to produce transgenic progeny. 713.7 was unable to
reproduce. Progeny from 706.6 were collected for phenotypic
and transgene expression analysis. RNA and protein expression
from the Prx1-Hoxd13 transgene was confirmed in progeny
from 706.6 by in situ hybridization and immunohistochemistry
(Figs. 1C–G). The transgenic offspring from 706.6 had a more
Fig. 1. Limb skeletal phenotype of representative (A) Prx1-Hoxd13 and (B) Prx1-Hoxa13 transgenic founders. Alcian blue stained left limbs from E16.5 transgenic
founder Prx1-Hoxd13 702.1 and Alcian blue and Alizarin red stained left limbs from E16.5 founder Prx1-Hoxa13 1130.1 compared to E16.5 wild-type littermates. s,
stylopod (humerus or femur); z, zeugopod (radius and ulna or tibia and fibula). (C–J) Transgene expression in progeny of Prx1-Hoxd13 706.6 and Prx1-Hoxa13 84.
Hoxd13 in situ hybridization on E11.5 (C) wild-type and (D) 706.6 transgenic progeny. HOXD13 whole-mount immunohistochemistry on E11.5 (E) wild-type and (F)
706.6 transgenic progeny. HOXA13 whole-mount immunohistochemistry on E12.5 (H) wild-type and (I) 84 transgenic progeny. (G, J) Pre-immune controls.
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birth. Overall, their limb phenotype was less severe than many
founders, illustrating the variability as expected for this strategy.
Similarly, a single female Prx1-Hoxa13 founder survived to
adulthood and produced progeny with a more severe phenotype
that were also not viable. The lethality in these offspring
precluded extensive analysis of this line. A single transgenic
embryo was collected and showed proximal limb transgenic
HOXA13 protein expression at E12.5 by whole-mount
immunohistochemistry (Figs. 1H–J).
These observations demonstrate that proximal expression of
HOXA13 or D13 in mouse forelimbs and hindlimbs causes
severe skeletal reductions in both the zeugopod and stylopod
and occasionally more proximal skeletal elements. Although
overall the effects of HOXD13 and HOXA13 were similar, the
average measures in the founders indicate that HOXD13 had a
slightly greater effect on limb reduction of proximal structures.
Furthermore, these effects establish a baseline for comparison
for subsequent protein alterations.
Hoxd11 expression throughout the developing limb causes size
reduction of stylopod bones
Hox group 11 genes are necessary for the development of the
zeugopodal elements of the limb (Davis et al., 1995; Wellik and
Capecchi, 2003). Morgan et al. (1992) and Goff and Tabin
(1997) showed that early retroviral misexpression of Hoxd11 in
the developing chick limb led to digit I to digit II conversion in
the leg. Preaxial polydactyly (digit II morphology) was
frequently observed in the wing, and a decrease in the lengths
of the tibia and fibula was found due to reduction in bone
growth. We anticipated that Prx-1 driven expression of a group
11 gene should lead to negative effects primarily in the stylopod
and potentially to zeugopod length, anterior digital poster-
iorization and/or preaxial polydactyly. To test this, three Prx1-
Hoxd11 transgenic founders were generated.
Founder analysis
Founders 911.1 and 868.2 were prepared for skeletal analysis
on their day of birth (P0). These two founders had no proximal
skeletal reductions but exhibited preaxial polydactyly in the
forelimbs (not shown; Supplementary Table 3). The third
founder, 30, was viable and able to produce some viable
transgenic progeny. The visible phenotype of founder 30
consisted of a single extra preaxial digit on the left forelimb
autopod, malocclusion and pigmentation defects on the top of
the head and along the body flank.
Transgenic progeny
Offspring from line 30 were analyzed for limb skeletal
phenotypes and RNA expression. P0 progeny from founder 30
show reductions in stylopod bones of both the fore- and
hindlimbs (Fig. 2A, Supplementary Table 3). These progeny
had no reductions in the zeugopod of the hindlimb and normal
digits; however, variable phenotypes were observed in the
anterior forelimb zeugopod and in the autopod. These additional
forelimb effects consisted of distal radius reduction withconversion of digit I to a triphalangeal digit or complete loss
of the radius with oligodactyly. Transgene RNA expression was
confirmed in transgenic embryos at E11.5 (Figs. 2B, C).
We hypothesized that the defects in our mice might be
secondary to the induction of anterior Shh activity and
subsequent activation of a more posterior Hox gene. It is well
known that upon ectopic Shh expression posterior Hoxd genes
can be induced on the anterior side of the developing limb bud
where they are not normally expressed (Laufer et al., 1994;
Niswander et al., 1994). Thus, we hypothesized a series of events
leading to ectopic activation of a Hox gene more posterior than
Hoxd11 in proximal forelimb regions of our transgenic mice.
To test this hypothesis, we analyzed Shh and Hoxd13
expression in developing limbs of transgenic embryos from
line 30 at E11.5. Shhwas found to be ectopically expressed at the
anterior margin of the forelimb bud (Figs. 2D, E) or observed
weakly along the entire anterior–posterior axis of the forelimb
bud associated with limb bud narrowing (photo not shown).
Moreover,Hoxd13was expressed farmore anterior and proximal
than normal in the forelimbs of these offspring (Figs. 2F, G).
These results suggest that the reduction defects observed in the
distal, anterior forelimb zeugopods of Prx1-Hoxd11 transgenic
progeny likely result from induction of ectopic Shh and Hoxd13
and consequently impart negative effects on anterior, distal
zeugopod growth (Fig. 1). Variation in the results by comparison
with Knezevic et al. (1997), Morgan et al. (1992) or Goff and
Tabin (1997) may result from the timing and/or overall level of
expression obtained in these two different systems.
In summary, expression of Hoxd11 throughout the develop-
ing limbs results in reduction of stylopodal elements of both the
fore- and hindlimbs in transgenic progeny. We also observed
ectopic Shh and Hoxd13 expression on the anterior margin of
the forelimb, resulting in confined preaxial skeletal alterations.
The characteristics of the preaxial-specific defects are distinct
from those observed with Prx1-Hoxa13 or Prx1-Hoxd13
transgenic expression, which show reduction of the entire
zeugopod and stylopod.
Prx-1 driven expression of Hoxa9 does not result in zeugopod
reduction, but alters patterning in the forelimb
The group 9 Hox genes are the most 3′ AbdB-like members
of the A and D clusters. We hypothesized that 3′members of the
AbdB-related group, such as Hoxa9, would not cause skeletal
reductions within the limb upon ectopic expression. If this
hypothesis is correct, HOXA9 would provide a reference from
which to evaluate more posterior Hox protein domains
important for posterior prevalence. Thus, Hoxa9 was expressed
in the Prx-1 transgenic system.
Founder analysis
Six Prx1-Hoxa9 founders were generated, and four were
viable and able to reproduce. The single transgenic male
founder, 20, did not transmit the Prx1-Hoxa9 transgene. The
three remaining female founders, 23, 55, and 69 were bred to
collect transgenic progeny for further analysis, and then each
female founder was subsequently prepared for skeletal analysis.
Fig. 2. Limb skeletal phenotype and transgene expression for Prx1-Hoxd11 progeny. (A) Alcian blue and Alizarin red stained limbs from two P0 progeny from founder
30, 30.1 and 30.2, compared to wild-type (the wild-type littermate was cannibalized, therefore a non-littermate P0 wild type was used for comparison). s, stylopod
(humerus or femur); z, zeugopod (radius and ulna or tibia and fibula). Asterisk denotes distal truncation of the radius associated with ectopic ZPA activity. Hoxd11 in
situ hybridization on E11.5 (B) wild-type and (C) line 30 Prx1-Hoxd11 transgenic embryos. Shh RNA expression at E11.5 in left forelimbs of (D) wild-type and (E)
line 30 Prx1-Hoxd11 transgenic embryos. Yellow arrow marks ectopic Shh expression. Hoxd13 RNA expression at E11.5 in right forelimbs of (F) wild-type and (G)
line 30 Prx1-Hoxd11 transgenic embryos. Red arrows indicate normal Hoxd13 expression boundary.
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all abnormalities were limited to the forelimbs (Fig. 3A,
Supplementary Table 4); all hindlimbs were completely normal.
Preaxial polydactyly, mirror image ulnar zeugopod and autopodduplications, absence of the humerus deltoid crest, and distal
reduction of the anterior zeugopod element were observed. The
forelimb phenotype of the HOXB8 transgenic mice (see Fig. 2
of Charite et al., 1994) appears similar to those of our HOXA9
Fig. 3. Prx1-Hoxa9 founder and progeny skeletal phenotypes and expression analysis. (A) Representative Prx1-Hoxa9 founder forelimb phenotypes (a) wild-type
stylopod and (b) transgenic founder 69 showing loss of the humerus deltoid crest (green arrow), (c) wild-type forelimb zeugopod and (d) transgenic founder 69
exhibiting mirror image duplication of the ulna. (B) Alcian blue and Alizarin red stained forelimbs from Prx1-Hoxa9 progeny from founders 23 and 55. s, scapula; h,
humerus; r, radius; u, ulna. Expression analyses on Prx1-Hoxa9 progeny. (C–F) Transgenic Hoxa9 expression by in situ hybridization at E11.5. (C) Wild-type, (D)
transgenic embryo from line 23, (E) wild-type and (F) transgenic embryo from founder 55. Shh expression in line 23 transgenic embryo forelimbs at (H) E10 and (J)
E11.5 compared to (G, I) wild-type. Yellow arrows mark ectopic Shh expression. HOXD13 protein expression in forelimbs from (K) wild-type and (L) line 23 Prx1-
Hoxa9 transgenic embryos at E11.5. (M) Pre-immune control. Hoxd13 RNA expression in forelimbs of (N) wild-type and (O) Prx1-Hoxa9 transgenic embryos from
founder 55 at E11.5. Red arrows indicate the normal anterior Hoxd13 expression boundary (protein, K–M; RNA, N, O).
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deltoid crest and polydactyly. No Prx1-Hoxa9 founders we
produced had zeugopod or stylopod shortening typical of
posterior prevalence. Other phenotypic outcomes in non-limb
sites were vertex skull defects, malocclusion and hair pigmen-
tation variation consistent with other Hox transgene effects.
Transgenic progeny
Offspring were collected from founders 23, 55 and 69.
Transgenic offspring were affected with the same types of
defects seen in the founders. However, malformations in P0
progeny from founders 55 and 69 were more severe, in the limb
and non-limb regions, resulting in lethality after birth. In these
offspring, additional defects were observed affecting only
forelimbs including loss of clavicles, partial to complete loss
of the stylopod and scapula and, in one limb only, a singlerudimentary cartilage element was present apparently where the
joint of the stylopod and zeugopod would have formed (photo
not shown). Viable progeny were obtained from line 23 and
showed variable preaxial polydactyly, occasional presence of an
extra zeugopodal element between the radius and ulna and
variable distal reduction of the radius as seen for some Prx1-
Hoxd11 mice (Fig. 3B). Line 23 progeny also displayed
malformations most frequently in the left forelimb, and when
both sides were affected, the left side was more severe.
Two transgenic embryos at E11.5 were recovered from
founder 55 for RNA expression analysis. In addition, the viable
progeny from line 23 were used to generate embryos for RNA
and protein expression analyses. Transgenic Hoxa9 RNA
expression was very high, throughout all limb buds of lines
23 and 55 embryos (Figs. 3C–F). Similar to the radial defects in
Prx1-Hoxd11 limbs, distal reduction of the radius and preaxial
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gene induction. Variable levels of ectopic anterior Shh expres-
sion were observed in line 23 embryo forelimbs consistent with
variable degrees of preaxial polydactyly (Figs. 3G–J). Of three
transgenic embryos analyzed at E10, only 1 exhibited an
anterior region of Shh expression in the left forelimb. This
suggests that the time of ectopic Shh expression initiation is
variable. In addition, two embryos examined at E11.5 showed
different levels of anterior ectopic Shh expression in the
forelimbs. These findings correlate well with the variation in
skeletal defects observed in line 23 forelimbs. This ectopic
expression was also most often seen on the left consistent with
the more frequent preaxial polydactyly and distal radius
truncations observed on that side. HOXD13 protein was also
ectopically induced on the anterior side of the Prx1-Hoxa9
forelimb buds with preaxial polydactyly (Figs. 3K–M). The
degree of transgenic HOXD13 expression correlated with the
extent of polydactyly and reduction of the distal radius seen in
line 23 progeny. Hoxd13 expression was also assessed in one
E11.5 embryo from line 55, which exhibited anterior, ectopic
expression similar to line 23 (Figs. 3N, O).
Overall, other than reduction of the deltoid crest, Prx-1
driven expression of Hoxa9 resulted in no length reduction of
skeletal elements in the stylopod or zeugopod consistent with
posterior prevalence. Similar to Hoxd11, transgenic Hoxa9
expression in the forelimb was able to induce anterior ectopic
Shh and Hoxd13 expression leading to secondary morpholog-
ical alterations in limb patterning.
Prx1-Hoxd13IQN>AAA results in proximal skeletal reductions in
mouse limbs
Retroviral misexpression of a DNA binding mutant of
HOXD13 (I47, Q50, N51 converted to alanine residues) in the
chick causes shortening of the zeugopod consistent with
posterior prevalence (Caronia et al., 2003). We sought to
determine whether this is also true in mice, as well as whether
more proximal elements are affected.
Founder analysis
Four transgenic Prx1-Hoxd13IQN>AAA founders were gene-
rated, each exhibited severe reductions within the proximal
fore and hindlimbs (Fig. 4A, Supplementary Table 5). Average
skeletal reductions in the forelimb were: humerus 41%, radius
68% and ulna 63%, and in the hindlimb were: femur 9.5%,
tibia 70.1% and fibula 51%. While mild digit malforma-
tions were observed, preaxial polydactyly or conversion of
digit I to a more posterior digit identity was not seen in any of
the founders.
Our results in mice confirm the studies of Caronia et al.
(2003) in chicks that I, Q, and N (amino acids 47, 50 and 51
of the homeodomain) are not necessary for posterior
prevalence. Since residues I, Q and N make base contacts
with the major groove of DNA and this mutant has severely
reduced DNA binding capability in vitro, it appears that
monomeric DNA binding capability is not necessary for
HOXD13 to interfere with the growth of proximal limbskeletal elements (Caronia et al., 2003; Gehring et al., 1994).
Moreover, if cofactor interaction is necessary for posterior
prevalence effects, these residues of the homeodomain are not
critical for that interaction.
HOXD13 proteins with proximal AbdB-like homeodomain
substitutions cause posterior prevalence
Even though monomeric group 13 HOX protein DNA
binding capability is not necessary for posterior prevalence, this
does not rule out a contribution of the homeodomain in
posterior prevalence. We sought to further test the contribution
of the homeodomain sequence using homeobox swaps. Two
transgene constructs were generated: Prx1-Hoxd13d11HD and
Prx1-Hoxd13a9HD, with either the HOXD11 or the HOXA9
homeodomain sequences replacing those of HOXD13. We
reasoned that, if posterior prevalence is controlled by the
homeodomain, then these homeodomain swap experiments
with d11HD and a9HD should mimic the phenotypes of Prx1-
Hoxd11 and Prx1-Hoxa9 mice.
Founder analysis
The skeletal phenotypes of three of five P0 Prx1-
Hoxd13d11HD founders (2, 3 and 11) were similar to those of
Prx1-Hoxd13 founders (Fig. 4B, Supplementary Table 6). The
forelimb zeugopod in founder 2 was absent, and in founders 1, 4
and 11 the zeugopods were severely reduced. More proximal
defects included loss of the humerus deltoid crest and in
founders 1, 2 and 11 mild malformation of the scapula. In the
hindlimbs, founders 2, 3 and 11 exhibited severe reduction of
zeugopodal skeletal elements, and founders 1 and 4 were mildly
malformed. Hindlimb stylopods from all founders were normal.
Three founders at E16.5 and two adult founders were
recovered from injection of Prx1-Hoxd13a9HD (Fig. 4B,
Supplementary Table 7). All of the founders had forelimb
malformations including reductions of the zeugopod and
stylopod, reduction of the scapula, polydactyly and oligo-
dactyly. Two of the five founders exhibited hindlimb
zeugopod defects. Founder 22 had mild lengthening of the
fibula, which was misarticulated with the femur. Founder
54 had mild reduction in the length of the zeugopod and
stylopod bones.
These results show that, within the context of the HOXD13
protein, a group 13 homeodomain, per se, is not necessary for
posterior prevalence effects to be exerted in the forelimb or
hindlimb zeugopod or stylopod. However, having a HOXD13
homeodomain, by comparison, appears to increase the severity
of skeletal reductions. When comparing hindlimbs, which are
not complicated by secondary effects caused by ectopic ZPA
activity, a group 11 homeodomain is more potent operating in
the context of upstream HOXD13 non-homeodomain residues
than a group 9 homeodomain. Transgenic expression of Prx1-
Hoxd13d11HD resulted in severe hindlimb zeugopod reduction
in 3 of 5 founders (2, 3 and 11, Supplementary Table 6) and mild
zeugopod reduction in the remaining 2 founders (1 and 4,
Supplementary Table 6), whereas transgenic expression of
Prx1-Hoxd13a9HD resulted in 1 of 5 founders exhibiting mild
Fig. 4. Limb skeletal phenotype of representative transgenic founders. Alcian blue and Alizarin red stained left limbs from P0 founders: (A) Prx1-Hoxd13IQN>AAA
founder 66 and (B) Prx1-Hoxd13d11HD founder 11 and Prx1-Hoxd13a9HD founders 22 and 54 compared to wild-type littermates. Prx1-Hoxd13a9HD 54 represents the
most severe reduction observed with this transgene construct. s, stylopod (humerus or femur); z, zeugopod (radius and ulna or tibia and fibula).
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Table 7).
The HOXD13 homeodomain in the context of HOXA9 is not
sufficient to cause posterior prevalence
To test whether the HOXD13 homeodomain is sufficient to
confer posterior prevalence capabilities to a more 3′ Hox
protein, the transgene Prx1-Hoxa9d13HD was constructed. This
construct consists of HOXA9 non-homeodomain regions
together with the HOXD13 homeodomain.Founder analysis
Three founders expressing the Prx1-Hoxa9d13HD transgene,
13, 20 and 42, were recovered and all were phenotypically
normal (photos not shown).
Transgenic progeny
Progeny were collected from all three founders for skeletal
and expression analyses. Transgenic offspring from founder 20
had variable forelimb phenotypes including no defects, mild
scapula defects, loss of the humerus deltoid crest and preaxial
polydactyly (Fig. 5A, and not shown). All progeny had
Fig. 5. Prx1-Hoxa9d13HD skeletal phenotype and expression analysis. (A) Alcian blue and Alizarin red stained limbs from two P0 progeny from founder 20 compared
to a wild-type littermate. A P0 pup from founder 42 exhibited a similar phenotype of preaxial polydactyly and no apparent shortening but was subsequently
cannibalized preventing complete skeletal analysis. s, scapula; h, humerus; r, radius; u, ulna. (B) In situ hybridization on E11.5 wild-type and transgenic embryos
from line 42 with a Hoxa9 RNA probe. Similar robust transgene expression for lines 20 and 13 was also confirmed by in situ hybridization (not shown). (C) Western
analysis on (1) HOXA9 positive control lysate, (2) transgenic line 42 proximal limb bud lysate, (3) transgenic line 42 distal limb bud lysate, (4) wild-type proximal
limb bud lysate, and (5) wild-type distal limb bud lysate. HOXA9 protein was not detected in the wild-type lysates at this antibody titer; in other blots using a higher
antibody concentration, HOXA9 was always detected more robustly in transgenic samples as compared to wild-type. The HOXD13 panel is a positive control
western using the same protein samples as used for the HOXA9 blot above and shows robust HOXD13 expression in the distal segments of both transgenic and wild-
type limb bud lysates.
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20 that had preaxial polydactyly died after birth. Since founder
20 was female, viable transgenic male offspring were used to
generate embryos for expression analyses. A single transgenic
pup from founder 42 appeared similar to progeny from founder
20 in that it had preaxial polydactyly and no obvious shortening
of the limbs. However, this pup died and was cannibalized
preventing thorough skeletal analysis. All transgenic progeny of
founder 13 had normal limbs.
Robust limb transgene RNA expression was observed in
embryo offspring from all three founders, 13, 20 and 42 (Fig.
5B, and data not shown). To confirm transgenic protein
expression, lysates from wild-type and transgenic limb buds
were collected at E12.5 to reduce the chance of detecting wild-type HOXA9 and analyzed by western blotting with an anti-
HOXA9 antibody. HOXA9 protein signal was much more
robust than wild-type in both proximal and distal transgenic
samples from lines 42 and 13, confirming the presence of the
chimeric protein in these transgenic limbs (Fig. 5C and data not
shown). The lack of skeletal reduction upon abundant ectopic
limb expression of HOXA9 containing the HOXD13 home-
odomain demonstrates that a group 13 homeodomain is not
sufficient in all contexts to confer dominant function in the limb.
Hox sensitivity to genetic manipulation of coding sequence
To precisely define protein regions that are necessary and
sufficient for posterior prevalence, several deletion/substitution
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removal of the homeodomain, replacement of the homeodomain
with a nuclear localization sequence and a series of N-terminal
deletion constructs. N-terminally truncated Hox proteins have
been reported to produce proximal skeletal reductions upon
retroviral misexpression in chick (Goff and Tabin, 1997). In our
experiments, deletion/substitution constructs produced normal
protein expression and nuclear localization in tissue culture cell
lines; however, in mice, the proteins could not be detected
despite robust RNA expression (data not shown). We therefore
altered our strategy to create a HOXD13 construct containing
comparably small amino acid changes as opposed to large
deletions.
A highly conserved 6-residue motif N-terminal to the HOXD13
homeodomain is not necessary for posterior prevalence
We sought to identify specific residues within the N-
terminal, non-homeodomain region of HOXD13 that might be
critical for posterior prevalence. Several highly conserved
protein motifs exist upstream of the homeodomain (Mortlock et
al., 2000). We selected six residues R, A, K, E, F and Y at
positions 182–185, 188 and 189 because they are conserved
among all group 13 proteins. Additionally, these residues were
retained within an amino-terminally truncated HOXD13 protein
that was sufficient to cause proximal limb reductions in chick
retroviral experiments (Goff and Tabin, 1997). To determine if
these residues are important to HOXD13 effects in the proximalFig. 6. Limbskeletalphenotypeofa representativePrx1-Hoxd13RAKEFY>GGGGGG
transgenic founder. Alcian blue and Alizarin red stained left limbs from P0
founder 994.3 compared to a wild-type littermate. s, stylopod (humerus or
femur); z, zeugopod (radius and ulna or tibia and fibula).limb, we created Prx1-Hoxd13RAKEFY>GGGGGG and evaluated
its function in transgenic mice.
Founder analysis
Five transgenic founders were obtained from injection of this
construct, three at P0, founders 994.1, 994.3 and 996.1 and two
adults, founders 22 and 51 (Fig. 6, Supplementary Table 8).
Proximal regions of both the forelimbs and hindlimbs in
founders 994.3 and 996.1 were severely shortened. Founders 22
and 994.1 exhibited mild zeugopod shortening and preaxial
polydactyly in both the fore- and hindlimbs. Founder 22 did not
transmit the transgene. The only detectable phenotype in
founder 51 was a slight pigmentation defect around the nose.
The transgene-specific PCR for this founder was extremely
weak compared to a single copy transgene standard, suggesting
possible mosaicism, which might explain the lack of a limb
abnormality.
HOXD13RAKEFY>GGGGGG expressed throughout the entire
developing limb resulted in severe skeletal reductions in the
zeugopod and stylopod similar to those observed for wild-type
HOX group 13 proteins. Therefore, this N-terminal motif,
RAKE–FY, is not necessary for posterior prevalence.
Discussion
A hierarchy of Hox function in the developing mouse limb
A transgenic approach using the murine Prx-1 promoter for
all experimental templates and comprehensive verification of
transgene RNA and protein expression was utilized to system-
atically test the effects of misexpression of specific Hox genes in
developing mouse limbs. The Prx1-Hox system used in our
study produced generally a more severe range of reductions than
those seen in previous studies using retroviral expression in
chick limbs or transgenic mice. Like other reports, the Prx1-Hox
transgenic mice also exhibited intra-construct variability in
phenotype and these effects are likely due to alterations in level
of expression due to transgene copy number variation and/or
insertion site effects. One additional limitation is that we did not
determine that the transgene was expressed in all founders;
however, we analyzed mice that showed transgene effects in
other areas of Prx-1 expression. Furthermore, despite the fact
that the Prx-1 transgene promoter recapitulates normal Prx-1
forelimb expression, there is a posterior hindlimb bud expression
delay (Martin and Olson, 2000). Thus, absence of an effect in
hindlimbs could represent the results of a delay in expression,
which in retroviral experiments can cause an absence of a visible
phenotype (Morgan et al., 1992). However, in the Prx1-Hoxa13
and Prx1-Hoxd13 transgenic founders, any effect of a delay in
expression was not apparent, and therefore the delay is not likely
a major cause of hindlimb phenotypic differences between
transgenes. As with other misexpression studies, our approach
can generate physiological as well as non-physiological effects
due to these alterations in timing and expression level. Despite
these limitations, we utilized multiple founders and offspring to
derive clear comparative conclusions regarding the capabilities
of the transgenic HOX proteins using this one system.
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studies with individual genes, we definitively demonstrated that
such a functional hierarchy exists in the developing mammalian
limb. Proximal expression of Hoxa13 or Hoxd13 results in
severe reductions of skeletal elements of the stylopod and
zeugopod. No length reductions were observed in the autopods
where Hoxa13 and Hoxd13 are normally expressed, as
expected. Proximal misexpression of Hoxd11 results in
reduction of skeletal elements of the stylopod, but no direct
negative effects in the normal domain of expression, the
zeugopod or the more distal autopod. All hindlimbs of the Prx1-
Hoxa9 transgenic mice were completely normal, as would be
expected for the most 3′ (proximal) AbdB-like Hox group
member expressed in the developing limb. The defects in the
forelimbs are interesting in that they are similar to those
documented for misexpression of Hoxb8, a gene for which
individual loss of function mutations do not cause limb defects
despite its expression early in the posterior limb bud
mesenchyme (van den Akker et al., 1999). It is possible that
the more proximal defects of the scapula and the humerus
deltoid crest are due to prevalence over HOXC6 or HOXC8
which have been implicated in the development of these
structures (Oliver et al., 1990; van den Akker et al., 2001).
Overall, the results from transgenic expression of Hoxd13,
Hoxa13, Hoxd11 and Hoxa9 throughout the developing mouse
limb provide direct evidence that a functional hierarchy exists
among Hox proteins in the context of normal limb development
(Fig. 7). This system and the observations reported here provide
a basis for future evaluation of sequence differences in the
AbdB Hox family and the critical functional domains that are
required for posterior prevalence.
Secondary patterning effects resulting from Hox
overexpression
Ectopic activation of polarizing activity or Shh in anterior
limb domains associated with digital conversion to posterior
identities and/or additional digits has been observed in chicks
and mice overexpressing HOX proteins (Caronia et al., 2003;
Charite et al., 1994; Chen et al., 2004; Goff and Tabin, 1997;
Kmita et al., 2005; Knezevic et al., 1997; Morgan et al., 1992;Fig. 7. A Hox group 13 homeodomain is neither necessary nor sufficient for poste
reduction in zeugopod skeletal elements. Transgenic expression of Hoxa9d13HD cause
regions exhibiting variable reduction. Effects of transgene expression on preaxial poZakany et al., 2004). Therefore, the occurrence of some degree
of preaxial polydactyly and/or mirror-image duplication in
all of our Hox constructs, except for Hoxd13IQN>AAA and
Hoxd13d11HD, was not surprising. This result was most often
observed in forelimbs in our studies. However, the frequency
and involvement of forelimbs or hindlimbs varied among the
mice.
However, distal radius shortening or absence observed in
Prx1-Hoxd11 and Prx1-Hoxa9 forelimbs prompted us to
determine whether this was also associated with ectopic, anterior
activation of HOXD13. A similar distal truncation of the radius
was observed in the studies of Knezevic et al. (1997) with
Hoxd12, and Hoxd12 or Hoxd11 were shown to induce the
expression of Shh in limbs and cultured cells. However, this
effect was not observed in the experiments with Hoxd11 (see
below) in chicks. We showed that in the Prx1-Hoxd11 and Prx1-
Hoxa9 lines Shh and Hoxd13 were ectopically activated in the
anterior region of the forelimbs, which likely resulted in the
distal radius reductions observed. In related work relative to
DNA binding capabilities, we confirmed the findings of Caronia
et al. (2003) in chicks showing that Prx1-Hoxd13IQN>AAA
transgenic mice had severe proximal malformations yet normal
digit number and identity. Thus, monomeric DNA binding
ability is not critical for posterior prevalence. However, ectopic
anterior activation of Shh activity, readily observed in Prx1-
Hoxa13 and Prx1-Hoxd13 transgenic mice, appears to depend
on this property.
Our results with Hoxd11 are partially consistent with
previous studies with Hoxd11 chick retroviral expression
(Morgan et al., 1992; Goff and Tabin, 1997). Both observed
partial conversion of digit I to a digit II fate but no polydactyly
in the leg, yet an extra digit in 46% of infected wings. Both
studies infected chick limb fields at very early stages (10–12)
of development, and complete infection of the limb fields with
overexpression of the genes was documented. Moreover, a 12-
hour delay in the timing of infection eliminated the effects
observed illustrating the importance of the timing of HOX
misexpression. None of our Prx1-Hoxd11 founders or offspring
showed hindlimb preaxial polydactyly. On the other hand, we
observed shortening of elements proximal to the normal
domain of expression, mainly affecting the stylopod. Morganrior prevalence. Transgenic expression of Hoxd13d11HD or Hoxd13a9HD caused
d no reduction of skeletal elements. Segment reductions in the diagram represent
lydactyly are not depicted.
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Tabin (1997) also documented a shortening of the tibia and
fibula in Hoxd11 infected hindlimbs. In the latter study, this
effect was related to a reduction in cell proliferation as a late
effect of HOXD11 on bone growth, not at the stages of
condensation. The reason for the variation in outcomes is not
known.
It is also curious that HOXA9 had such a strong effect on the
forelimb in our experiments, inducing not only extra digits but
also ulnar duplication, yet absence of any observable effect in
hindlimbs. This effect was observed not only in Prx1-Hoxa9
transgenic founders, but also in numerous offspring of two lines
with striking forelimb involvement. HOXD9 chick limb bud
infection (Morgan et al., 1992) resulted in no phenotype. It is
intriguing that HOXD9 is expressed throughout the early fore-
and hindlimb buds in chick, whereas HOXA9 starts out
uniformly in both but develops early on a region of absent
expression in the anterior/proximal forelimb bud (Nelson et al.,
1996). Perhaps Prx-1 transgenic expression throughout the
forelimb domain, including this anterior/proximal region, more
easily promotes ectopic anterior hedgehog activity and does not
induce hindlimb patterning effects because HOXA9 is
expressed throughout.
Non-homeodomain regions of HOXD13 are necessary for
posterior prevalence
Due to the highly conserved nature of the Hox home-
odomain and its ability to bind DNA, the main role of Hox
proteins during development is thought to be direct transcrip-
tional regulation of target genes. This idea has been supported
by many studies in Drosophila, both in vitro and in vivo,
showing activation and repression of target gene transcription
(Gehring, 1993). The importance of the homeodomain in Hox
function during development has made it a major focus in
studies exploring the mechanism(s) through which specificity
is achieved by different Hox proteins. Evidence from
Drosophila misexpression experiments largely supports a
critical role of the homeodomain in determining unique Hox
effects in vivo (Furukubo-Tokunaga et al., 1993; Gibson et al.,
1990; Kuziora and McGinnis, 1989, 1990; Lin and McGinnis,
1992; Zeng et al., 1993). These studies support the conclusion
that unique amino acids of the homeodomains of different Hox
proteins alter DNA site recognition and hence target specificity.
Other fly studies have demonstrated non-homeodomain con-
tributions to unique function and a difference in the non-
homeodomain protein regions required for specificity depend-
ing on the tissue of expression (Chauvet et al., 2000; Merabet et
al., 2003). These observations support consideration of
alternative mechanisms that have been proposed for Hox
functional specificity such as cofactor interactions, inherent
Hox activation or repression capabilities or activity regulation
by the context of the DNA sequences bound (Capovilla and
Botas, 1998; Chan et al., 1994; Chauvet et al., 2000; Li and
McGinnis, 1999; Li et al., 1999).
In mammals, the involvement of different protein regions
appears to depend on the tissue context as well (Sreenath et al.,1996; Zhao and Potter, 2001, 2002). These experiments, similar
to those in Drosophila, support the notion that Hox proteins
exploit multiple mechanisms to gain functional specificity.
Caronia et al. (2003) showed that monomeric DNA binding
capability, per se, and HD residues I47, Q50 and N51,
specifically, are not necessary for posterior prevalence in
chicken retroviral misexpression experiments. We confirmed
this result and extended the analysis with chimeric proteins to
show that the HOXD13 homeodomain is neither necessary nor
sufficient for posterior prevalence (Fig. 7). Both Hoxd13d11HD
and Hoxd13a9HD proteins were sufficient to exert posterior
prevalence effects. However, the homeodomain appears to
affect the severity of overall skeletal shortening, as demonstrat-
ed by Prx-1 driven expression of Hoxd13a9HD as compared to
HOXD13. Proximal expression of the chimeric Hoxd13a9HD
protein resulted in only one founder with hindlimb zeugopod
reductions. In contrast, Prx-1 driven HOXA9 never caused
hindlimb defects, further supporting the conclusion that the
HOXD13 non-homeodomain regions are able to cause posterior
prevalence albeit less effectively. While the ability of the
homeodomain to influence posterior prevalence was not
unexpected, we did not anticipate that chimeric proteins without
the HOXD13 HD would be capable of such effects based on the
prior literature. To begin to determine the non-homeodomain
regions of HOXD13 critical for the effects observed here, we
made glycine substitutions for six conserved group 13 N-
terminal residues (RAKE-FY) within HOXD13. These altera-
tions to the HOXD13 protein did not inhibit its ability to exert
posterior prevalence. We believe that creating point mutations
to address the protein domain(s) necessary for posterior
prevalence will be an effective method for identification of
the region within the HOXD13 non-homeodomain portion that
is critical for posterior prevalence in the future. The data support
further efforts to define the critical non-homeodomain regions
of group 13 proteins and the precise residues within the
homeodomain that contribute to posterior prevalence.
This transgenic system will be useful in the future for
identifying the molecular defects associated with proximal
expression of distal HOX proteins. A systematic evaluation of
genes suggested to play a role in a proximal limb program such
as Gli3, Plzf and Meis may yield insight into the mechanism by
which Hox proteins exert such selective interference upon
misexpression (Barna et al., 2005; Mercader et al., 1999).
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